Claudia Raineri
Overview
Explore the profile of Claudia Raineri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
1343
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Angelini F, Bocchino P, Dusi V, Pidello S, De Ferrari G, Raineri C
Eur Heart J Suppl
. 2025 Feb;
27(Suppl 1):i40-i46.
PMID: 39980777
Hypertrophic cardiomyopathy (HCM) is a genetic condition primarily caused by mutations in sarcomeric proteins, leading to abnormal thickening of the left ventricular wall. Although HCM is the most common genetic...
2.
Cacioli G, Gallone G, Verde A, Ciabatti M, Pidello S, Colombo V, et al.
Can J Cardiol
. 2025 Feb;
PMID: 39956377
Background: Angiotensin receptor-neprilysin inhibitors (ARNI) intolerance is common in patients suffering advanced heart failure (AdHF) and may be associated with worse prognosis. During right heart catheterization (RHC), afterload reduction induced...
3.
Leo I, Dellegrottaglie S, Scatteia A, Torella D, Abete R, Aquaro G, et al.
Eur Heart J Cardiovasc Imaging
. 2025 Feb;
PMID: 39899463
Background: Accurate risk stratification for patients with non-dilated left ventricular cardiomyopathy (NDLVC) remains challenging due to lack of dedicated clinical trials. This post-hoc analysis aims to delineate the arrhythmic risk...
4.
Gasecka A, Jasinska-Gniadzik K, DAscenzo F, Angelini F, Lomiak M, Pregowski J, et al.
Am J Cardiol
. 2024 Nov;
238:12-20.
PMID: 39613282
The Cardiovascular Outcomes Assessment for Heart Failure Patients with Functional Mitral Regurgitation (COAPT) risk score predicts the risk of death or hospitalization for heart failure within 2 years after transcatheter...
5.
Frea S, Pidello S, Angelini F, Boretto P, Bocchino P, Melis D, et al.
J Cardiovasc Dev Dis
. 2024 Nov;
11(11).
PMID: 39590216
Background: Heart transplantation and left ventricular assist device (LVAD) implementation are effective treatments for advanced heart failure (HF), although their use is limited by organ availability and the high incidence...
6.
AlAref S, Gautam N, Mansour M, Alqaisi O, Tarun T, Devabhaktuni S, et al.
Int J Cardiol
. 2024 Nov;
419:132709.
PMID: 39515617
Aims: While factors associated with adverse events are well elucidated in setting of isolated left ventricular dysfunction, clinical and imaging-based prognosticators of adverse outcomes are lacking in context of biventricular...
7.
Ammirati E, Varrenti M, Sormani P, Bernasconi D, Moro C, Grosu A, et al.
Int J Cardiol
. 2024 Sep;
417():132567.
PMID: 39299393
Background: Identifying markers associated with adverse events after acute myocarditis (AM) is relevant to plan follow-up. We assessed the prognostic performance of previously described cardiac magnetic resonance imaging (CMRI) markers...
8.
Angelini F, Ravera F, Gobello G, Manai R, Bocchino P, Barreca A, et al.
Can J Cardiol
. 2024 Sep;
40(12):2589-2591.
PMID: 39277076
No abstract available.
9.
Manzi G, Benza R, Argiento P, Casu G, Corda M, Correale M, et al.
Vascul Pharmacol
. 2024 Sep;
157:107432.
PMID: 39265796
Despite the innovations introduced in the 2022 European Society of Cardiology/European Respiratory Society Guidelines on Pulmonary Hypertension, risk discrimination and management of pulmonary arterial hypertension (PAH) patients at intermediate risk...
10.
Frea S, Gravinese C, Boretto P, De Lio G, Bocchino P, Angelini F, et al.
Eur Heart J Acute Cardiovasc Care
. 2024 Jul;
13(9):646-655.
PMID: 39012797
Aims: Haemodynamic assessment can be determinant in phenotyping cardiogenic shock (CS) and guiding patient management. Aim of this study was to evaluate the correlation between echocardiographic and invasive assessment of...